Thursday, June 12, 2008
« oooh baby it's the nerd girls | Main | NETS-T »
FDA Drug Safety Newsletter
In This Issue


Postmarketing Reviews

PemetrexedReports of radiation recall associated with pemetrexed (marketed as ALIMTA) NatalizumabReports of serious liver injury associated with natalizumab (marketed as TYSABRI)

CarbamazepineReports of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with carbamazepine (marketed as CARBATROL, EQUETRO, TEGRETOL and other associated generics) in Asians positive for the HLA-B*1502 allele
New Molecular Entity (NME) - 3 Years Later
Feature Article

Drug Safety CommunicationsList of advisories on drug safety posted on FDA’s Web site from January 1, 2008 through April 30, 2008, with related links
NetHappenings Mailing List | Science
Thursday, June 12, 2008 4:22:00 PM (Eastern Daylight Time, UTC-04:00)    Disclaimer  |  Comments [0]  |  Related posts:
First Women Computers
Multi Processor Computing 1924
OSHA Uncensored
Make Your Power Company Carbon-Free
Palin Republican nominee for VP
FCC Begins to Resolve Mutually Exclusive Noncommercial FM Radio Applications